Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. [electronic resource]
- Brain research. Molecular brain research Dec 2002
- 45-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0169-328X
10.1016/s0169-328x(02)00488-6 doi
Adult Aged Aged, 80 and over Alzheimer Disease--metabolism Animals Brain--anatomy & histology Female Fluorescent Dyes--metabolism Humans Immunohistochemistry MAP Kinase Kinase 1 MAP Kinase Kinase 2 Male Middle Aged Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinase Kinases--metabolism Mitogen-Activated Protein Kinases--metabolism Neurofibrils--metabolism Neurons--cytology Phosphorylation Protein Serine-Threonine Kinases--metabolism Protein-Tyrosine Kinases--metabolism Up-Regulation--physiology tau Proteins--metabolism